Clinical Trials
5
Active:5
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
58
EMC:58
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)No trials found
News
Glofitamab Approved by NHS as Potential Curative Treatment for Aggressive Blood Cancer
The NHS has approved glofitamab (Columvi®) for diffuse large B-cell lymphoma (DLBCL) patients who have undergone two or more ineffective treatments.